News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts

Spotlight -

Downstream Processing|

Upstream Processing

|Articles|August 31, 2006

Genelabs Appoints VP of Biology

Author(s)BioPharm International Editors

Genelabs Technologies, Inc. (Redwood City, CA, www.genelabs.com) has appointed Peter R. Young, PhD, to the position of vice president, biology.

Genelabs Technologies, Inc. (Redwood City, CA, www.genelabs.com) has appointed Peter R. Young, PhD, to the position of vice president, biology. Young joins Genelabs from Celera Genomics.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Content

T-Cells Work to Fight Cancer, Immunotherapy, CAR T-cell therapy, 3d rendering | Image credit: © Design Cells - © Design Cells - stock.adobe.com

New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline

ByFeliza Mirasol

December 5th 2025

Parkinson's disease. 3D illustration showing neurons containing Lewy bodies small red spheres which are deposits of proteins (alpha-synuclein) accumulated in the brain cells. | Image credit: © Lars Neumann - © Lars Neumann - stock.abode.com

Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies

ByFeliza Mirasol

December 4th 2025

small interfering RNA bound to a messenger RNA, cartoon model with semi-transparent surface. siRNAs are synthetic RNA interference tools used for inducing temporary reduction of mRNA expression. | Image credit: © petarg - © petarg - stock.adobe.com

Emerging siRNA Platform Offers New Metabolic Disorder Therapies

ByFeliza Mirasol

December 3rd 2025

Exosomes, cross section showing proteins and mRNA | Image credit: © Juan Gärtner - © Juan Gärtner - stock.adobe.com

How Engineered Exosomes Can Impact Targeted Therapies

ByFeliza Mirasol

December 3rd 2025

Creative image of embryonic stem cells, cellular therapy. 3d illustration | Image credit: © pinkeyes - © pinkeyes - stock.adobe.co

Implementing Automation and Flexible Design for Allogeneic Manufacturing

ByJennifer Markarian

December 2nd 2025

Trending on BioPharm International

New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline

Implementing Automation and Flexible Design for Allogeneic Manufacturing

Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies

Emerging siRNA Platform Offers New Metabolic Disorder Therapies

New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models

© 2025 MJH Life Sciences^®

All rights reserved.